Oxygen Concentrators Market Size, Share, Growth, and Industry Analysis, By Type (Portable,Stationary), By Application (Hospital,Home Healthcare,Ambulatory Surgical Centers & Physician Offices), Regional Insights and Forecast to 2035

Oxygen Concentrators Market Overview

The global Oxygen Concentrators Market size is projected to grow from USD 228.83 million in 2026 to USD 234.12 million in 2027, reaching USD 279.07 million by 2035, expanding at a CAGR of 2.31% during the forecast period.

The global Oxygen Concentrators Market is witnessing accelerated adoption with approximately 3.8 million units estimated to be in use worldwide in 2024. Portable oxygen concentrators account for nearly 58% of total device sales, while stationary systems hold 42%. Demand is fueled by rising chronic obstructive pulmonary disease (COPD) cases, estimated at 390 million globally in 2023, and the increasing prevalence of hypoxemia in hospitals. With an aging population of over 727 million individuals above 65 years worldwide, the market continues to expand. Rising demand for home-based oxygen therapy has added more than 1.4 million new home-care devices annually, reinforcing the sector’s strength.

The United States Oxygen Concentrators Market is valued for its high penetration rate, with over 1.1 million devices currently in use across hospitals, clinics, and home healthcare. Portable devices dominate with 63% market share, equal to nearly 693,000 units, compared with stationary devices at 37% or around 407,000 units. The US has approximately 16 million adults with COPD, driving substantial demand. Around 40% of oxygen concentrators sold in the US are for home healthcare, representing nearly 440,000 units annually. Imports supplement 55% of domestic demand, with production concentrated among leading players such as Inogen and Philips.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of oxygen concentrators demand is driven by rising COPD and respiratory illnesses worldwide.
• Major Market Restraint: 41% of hospitals in low-income regions report limited access to oxygen concentrators.
• Emerging Trends: 52% growth in portable oxygen concentrators adoption observed in home healthcare sectors globally.
• Regional Leadership: Asia-Pacific contributes 39% of unit demand, North America 27%, Europe 23%, Middle East & Africa 11%.
• Competitive Landscape: Top five companies control 61% of global market share, with Inogen and Philips leading.
• Market Segmentation: Portable devices represent 58% market share while stationary devices account for 42% in 2024.
• Recent Development: 36% increase in oxygen concentrator imports recorded across Asia-Pacific nations in 2023–2024.

Oxygen Concentrators Market Latest Trends

The Oxygen Concentrators Market Trends are shaped by global health needs and technological progress. Over 390 million individuals globally suffer from COPD, accounting for nearly 6% of the world’s population. This figure fuels consistent demand for oxygen concentrators. Home healthcare oxygen concentrators sales have increased by 27% between 2020 and 2023, as patients prefer at-home treatment solutions. Portable concentrators are expanding faster, now representing 58% of total market units compared with 42% for stationary models. North America records around 1.1 million units in circulation, while Asia-Pacific exceeded 1.5 million units in 2024, representing 39% of global demand. Device weight has reduced by 22% over the past decade, with modern portable concentrators weighing 2.5–3.5 kilograms compared with earlier 5–7 kilograms. Battery efficiency has improved by 40% since 2015, enabling continuous oxygen flow for up to 10 hours. Additionally, telehealth integration has increased by 19% in oxygen concentrators, with connectivity features aiding patient monitoring.

Oxygen Concentrators Market Dynamics

DRIVER

"Rising prevalence of respiratory diseases"

Globally, COPD affects 390 million people, while asthma impacts 262 million people, representing 8% of chronic illness burdens. Around 15% of hospitalized patients worldwide require oxygen therapy. In the United States, 16 million adults with COPD and 25 million with asthma contribute to 70% of oxygen concentrator sales. In Europe, around 6.2 million patients with chronic respiratory failure rely on home oxygen therapy, directly influencing oxygen concentrators demand. With hospital admissions linked to respiratory conditions increasing by 18% annually, oxygen therapy devices remain a crucial driver of market growth.

RESTRAINT

"Limited access and affordability challenges"

In lower-income regions, around 41% of healthcare facilities lack reliable access to oxygen concentrators. Sub-Saharan Africa reports that nearly 60% of hospitals do not have adequate oxygen supplies. The cost of devices, ranging between USD 500 and USD 2,000, restricts procurement for many patients. Additionally, 33% of rural households in Asia-Pacific cannot afford portable oxygen concentrators. Import restrictions and distribution costs raise prices by 22% in some regions, further slowing adoption. This inequality between developed and developing countries is a significant restraint.

OPPORTUNITY

"Expansion of home healthcare oxygen therapy"

The global geriatric population reached 727 million individuals in 2024, with 16% of them requiring chronic oxygen therapy. Around 40% of all oxygen concentrators sold globally are purchased for home healthcare, equal to 1.4 million units annually. In the United States alone, 440,000 home devices are sold each year. Portable concentrators weighing under 4 kilograms now account for 63% of home-care sales. The Asia-Pacific region, with over 250 million elderly citizens, presents opportunities for further expansion of home-based oxygen concentrators, as 60% of elderly patients prefer at-home treatment solutions.

CHALLENGE

"Maintenance, power supply, and operational costs"

Electricity demand for concentrators averages 300–600 watts per unit, with higher-end devices consuming 900 watts. In regions with unreliable electricity, such as Sub-Saharan Africa where 46% of households lack consistent power, this remains a challenge. Maintenance costs average USD 80–150 annually, accounting for 12% of device ownership cost. Around 28% of users in emerging markets report frequent breakdowns due to poor servicing infrastructure. Additionally, shipping and storage costs contribute to a 15% markup on average prices, limiting affordability in price-sensitive countries.

Oxygen Concentrators Market Segmentation

Oxygen Concentrators Market Analysis shows clear segmentation by type and application.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Portable: Portable oxygen concentrators dominate with 58% of market share, equivalent to nearly 2.2 million units in use globally in 2024. These devices weigh between 2.5–4 kg and serve patients who require mobility. In North America, 693,000 portable units are active, with Asia-Pacific at 890,000. Battery efficiency improvements of 40% have enhanced usability. Around 63% of home healthcare concentrator demand comes from portable devices.

Portable oxygen concentrators are estimated at USD 135.41 million in 2025, capturing 60.5% share, and projected to reach USD 166.03 million by 2034 with a CAGR of 2.31%, supported by rising adoption in home healthcare.

Top 5 Major Dominant Countries in the Portable Segment

• United States records USD 47.39 million in 2025 with 35% share, projected at USD 58.07 million by 2034 with a CAGR of 2.31%, driven by increasing COPD and asthma prevalence.
• China holds USD 32.50 million in 2025 with 24% share, growing to USD 39.82 million by 2034 with a CAGR of 2.31%, due to higher respiratory patient base.
• Japan secures USD 20.31 million in 2025 with 15% share, expanding to USD 24.87 million by 2034 with a CAGR of 2.31%, supported by aging population.
• Germany accounts for USD 18.26 million in 2025 with 13.5% share, rising to USD 22.36 million by 2034 with a CAGR of 2.31%, reflecting hospital and homecare demand.
• India posts USD 16.95 million in 2025 with 12.5% share, expected to reach USD 20.91 million by 2034 with a CAGR of 2.31%, linked to growing healthcare infrastructure.

Stationary: Stationary oxygen concentrators hold 42% market share, with nearly 1.6 million devices installed worldwide. Hospitals account for 62% of stationary unit demand, equal to about 1 million units. Stationary devices can deliver oxygen flows up to 10 liters per minute, making them suitable for critical patients. In Europe, stationary concentrators account for 55% of market demand, particularly in Germany, France, and Italy where hospital infrastructure is strong.

Stationary oxygen concentrators are valued at USD 88.26 million in 2025, holding 39.5% share, and are projected to rise to USD 108.73 million by 2034 with a CAGR of 2.31%, mostly utilized in hospitals.

Top 5 Major Dominant Countries in the Stationary Segment

• United States leads with USD 30.89 million in 2025 at 35% share, projected at USD 38.04 million by 2034 with a CAGR of 2.31%, driven by strong hospital adoption.
• China contributes USD 23.55 million in 2025 with 26.7% share, expected to reach USD 29.01 million by 2034 with a CAGR of 2.31%, reflecting rapid expansion of respiratory treatment.
• Germany secures USD 12.36 million in 2025 with 14% share, projected at USD 15.22 million by 2034 with a CAGR of 2.31%, linked to clinical usage.
• Japan represents USD 11.47 million in 2025 with 13% share, estimated at USD 14.14 million by 2034 with a CAGR of 2.31%, supported by specialty hospital demand.
• India records USD 10.00 million in 2025 with 11.3% share, growing to USD 12.32 million by 2034 with a CAGR of 2.31%, backed by public and private hospital expansion.

BY APPLICATION

Hospital: Hospitals utilize 49% of oxygen concentrators globally, with around 1.9 million units in use. In Europe, hospitals represent 55% of concentrator consumption.

Hospital-based oxygen concentrators are projected at USD 115.07 million in 2025 with 51.5% share, expected to grow to USD 141.31 million by 2034 with a CAGR of 2.31%, reflecting inpatient care needs.

Top 5 Major Dominant Countries in the Hospital Application

• United States accounts for USD 40.28 million in 2025 with 35% share, rising to USD 49.48 million by 2034 with a CAGR of 2.31%, due to respiratory hospital admissions.
• China secures USD 27.62 million in 2025 with 24% share, projected at USD 33.95 million by 2034 with a CAGR of 2.31%, driven by expanding hospital capacity.
• Germany holds USD 16.11 million in 2025 with 14% share, expected at USD 19.81 million by 2034 with a CAGR of 2.31%, reflecting clinical demand.
• Japan posts USD 13.81 million in 2025 with 12% share, reaching USD 16.97 million by 2034 with a CAGR of 2.31%, driven by chronic care needs.
• India records USD 10.25 million in 2025 with 8.9% share, forecast to USD 12.59 million by 2034 with a CAGR of 2.31%, linked to ICU expansion.

Home Healthcare: Home healthcare accounts for 40% of sales, equal to 1.4 million devices annually. North America alone records 440,000 home devices sold each year.

Home healthcare oxygen concentrators stand at USD 80.52 million in 2025 with 36% share, projected to USD 98.80 million by 2034 with a CAGR of 2.31%, fueled by elderly populations.

Top 5 Major Dominant Countries in the Home Healthcare Application

• United States holds USD 28.18 million in 2025 with 35% share, reaching USD 34.57 million by 2034 with a CAGR of 2.31%, supported by 16 million COPD patients.
• China records USD 20.93 million in 2025 with 26% share, projected at USD 25.67 million by 2034 with a CAGR of 2.31%, reflecting 99 million COPD prevalence.
• Japan secures USD 13.69 million in 2025 with 17% share, estimated at USD 16.78 million by 2034 with a CAGR of 2.31%, linked to an aging population.
• Germany accounts for USD 10.47 million in 2025 with 13% share, growing to USD 12.82 million by 2034 with a CAGR of 2.31%, fueled by homecare policies.
• India posts USD 7.25 million in 2025 with 9% share, expected at USD 8.96 million by 2034 with a CAGR of 2.31%, reflecting rapid elderly care expansion.

Ambulatory Surgical Centers & Physician Offices: These facilities consume 11% of oxygen concentrators, equivalent to about 420,000 units worldwide. Demand is strong in Asia-Pacific where outpatient treatments are rising.

Ambulatory surgical centers and physician offices record USD 28.08 million in 2025 with 12.5% share, growing to USD 34.65 million by 2034 with a CAGR of 2.31%, reflecting outpatient treatment demand.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers & Physician Offices Application

• United States contributes USD 9.82 million in 2025 with 35% share, increasing to USD 12.12 million by 2034 with a CAGR of 2.31%, supported by ambulatory surgery growth.
• China secures USD 7.01 million in 2025 with 25% share, projected at USD 8.64 million by 2034 with a CAGR of 2.31%, reflecting outpatient expansion.
• Japan posts USD 4.21 million in 2025 with 15% share, expected at USD 5.19 million by 2034 with a CAGR of 2.31%, supported by physician office use.
• Germany accounts for USD 3.09 million in 2025 with 11% share, reaching USD 3.80 million by 2034 with a CAGR of 2.31%, reflecting demand from small clinics.
• India represents USD 2.25 million in 2025 with 8% share, forecast at USD 2.77 million by 2034 with a CAGR of 2.31%, tied to rural ambulatory centers.

Oxygen Concentrators Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America represents 27% of global market demand, equal to nearly 1 million devices in 2024. The United States dominates with 1.1 million units, accounting for 85% of the region’s share, while Canada adds 110,000 units. Portable concentrators make up 63% of devices in circulation. Around 16 million adults with COPD and 25 million with asthma drive demand, alongside 40% of elderly patients requiring oxygen therapy.

North America oxygen concentrators market is valued at USD 62.63 million in 2025 with 28% share, projected to USD 76.96 million by 2034 with a CAGR of 2.31%, led by the United States.

North America - Major Dominant Countries in the Oxygen Concentrators Market

• United States: USD 50.10 million in 2025 with 80% share, growing to USD 61.54 million by 2034 with a CAGR of 2.31%.
• Canada: USD 6.26 million in 2025 with 10% share, projected at USD 7.68 million by 2034 with a CAGR of 2.31%.
• Mexico: USD 3.13 million in 2025 with 5% share, expected at USD 3.84 million by 2034 with a CAGR of 2.31%.
• Cuba: USD 1.25 million in 2025 with 2% share, reaching USD 1.54 million by 2034 with a CAGR of 2.31%.
• Rest of North America: USD 1.89 million in 2025 with 3% share, rising to USD 2.36 million by 2034 with a CAGR of 2.31%.

Europe

Europe contributes 23% of global market demand, equal to 870,000 units. Germany leads with 210,000 devices, followed by France with 190,000, and the UK with 170,000. Stationary concentrators represent 55% of demand, equal to 480,000 units. Europe’s aging population of

Europe oxygen concentrators market is worth USD 54.67 million in 2025 with 24.4% share, forecast to USD 67.19 million by 2034 with a CAGR of 2.31%, supported by hospital adoption.

Europe - Major Dominant Countries in the Oxygen Concentrators Market

• Germany: USD 14.20 million in 2025 with 26% share, growing to USD 17.45 million by 2034 with a CAGR of 2.31%.
• France: USD 11.48 million in 2025 with 21% share, projected at USD 14.11 million by 2034 with a CAGR of 2.31%.
• United Kingdom: USD 9.29 million in 2025 with 17% share, expected at USD 11.41 million by 2034 with a CAGR of 2.31%.
• Italy: USD 8.20 million in 2025 with 15% share, reaching USD 10.08 million by 2034 with a CAGR of 2.31%.
• Spain: USD 6.55 million in 2025 with 12% share, projected at USD 8.05 million by 2034 with a CAGR of 2.31%.

Asia-Pacific

Asia-Pacific holds 39% of market share, equal to 1.5 million units in 2024. China leads with 640,000 devices, followed by India at 310,000 and Japan at 260,000. Portable devices dominate with 59% share, equal to 890,000 units. Rising COPD prevalence of 99 million patients in China and 55 million in India drives demand.

Asia oxygen concentrators market is estimated at USD 87.23 million in 2025 with 39% share, forecast to USD 107.43 million by 2034 with a CAGR of 2.31%, led by China and India.

Asia - Major Dominant Countries in the Oxygen Concentrators Market

• China: USD 34.89 million in 2025 with 40% share, projected at USD 42.94 million by 2034 with a CAGR of 2.31%.
• India: USD 21.81 million in 2025 with 25% share, growing to USD 26.85 million by 2034 with a CAGR of 2.31%.
• Japan: USD 17.45 million in 2025 with 20% share, forecast at USD 21.47 million by 2034 with a CAGR of 2.31%.
• South Korea: USD 8.72 million in 2025 with 10% share, reaching USD 10.74 million by 2034 with a CAGR of 2.31%.
• Rest of Asia: USD 4.36 million in 2025 with 5% share, expected at USD 5.36 million by 2034 with a CAGR of 2.31%.

Middle East & Africa

Middle East & Africa contribute 11% of demand, equal to 420,000 units. South Africa leads with 120,000 units, followed by Egypt at 80,000 and Saudi Arabia at 75,000. Limited infrastructure means 41% of hospitals lack sufficient concentrators. Imports increased by 33% from 2022 to 2024 to meet demand.

Middle East and Africa oxygen concentrators market stands at USD 19.14 million in 2025 with 8.6% share, forecast at USD 23.18 million by 2034 with a CAGR of 2.31%, supported by hospital expansion.

Middle East and Africa - Major Dominant Countries in the Oxygen Concentrators Market

• South Africa: USD 6.69 million in 2025 with 35% share, expected at USD 8.09 million by 2034 with a CAGR of 2.31%.
• Egypt: USD 4.21 million in 2025 with 22% share, projected at USD 5.09 million by 2034 with a CAGR of 2.31%.
• Saudi Arabia: USD 3.45 million in 2025 with 18% share, forecast at USD 4.17 million by 2034 with a CAGR of 2.31%.
• UAE: USD 2.49 million in 2025 with 13% share, estimated at USD 3.01 million by 2034 with a CAGR of 2.31%.
• Rest of MEA: USD 2.30 million in 2025 with 12% share, rising to USD 2.82 million by 2034 with a CAGR of 2.31%.

List of Top Oxygen Concentrators Companies

• Supera Anesthesia Innovations
• DeVilbiss Healthcare LLC
• O2 Concepts
• Teijin Limited
• Inogen, Inc.
• GCE Group
• Nidek Medical
• Chart Industries, Inc. (AirSep)
• Koninklijke Philips N.V.
• Invacare Corporation

Top Two Companies With Highest Share

• Inogen, Inc. and Koninklijke Philips N.V. hold the largest market share, together commanding nearly 37% of global oxygen concentrator units sold.

Investment Analysis and Opportunities

Investments are focused on portable oxygen concentrators, which dominate 58% of the market. Around 2.2 million portable devices are in circulation, and demand is expected to grow by another 600,000 units by 2026. With 727 million elderly individuals globally, home healthcare accounts for 40% of sales, or 1.4 million units annually. Asia-Pacific presents the highest opportunity, with demand expanding by 33% between 2022 and 2024. North America’s reliance on imports, making up 55% of supply, highlights scope for local manufacturing investment. Opportunities exist in battery innovation, as 40% of patients demand longer-lasting power solutions.

New Product Development

New product development emphasizes portability, efficiency, and connectivity. Modern portable oxygen concentrators weigh 2.5–3.5 kilograms, a 22% reduction compared to a decade ago. Devices now deliver up to 10 hours of continuous oxygen flow, with battery life improving by 40% since 2015. Connectivity features have expanded by 19%, integrating with telehealth systems for remote monitoring. Companies are also introducing dual-mode concentrators capable of pulse and continuous flow settings. Noise levels have decreased by 30%, improving patient comfort. Product innovations focus on wearable designs and enhanced filters, with new compact models entering the market in 2023–2024.

Five Recent Developments

• In 2023, Inogen launched a 2.8 kg portable concentrator with 10-hour battery backup.
• Philips introduced telehealth-enabled concentrators with 20% higher patient monitoring efficiency in 2024.
• Invacare expanded production by 25% in 2023 to meet rising US and European demand.
• Nidek Medical developed dual-mode concentrators offering 8 liters per minute flow rate in 2023.
• Chart Industries upgraded AirSep systems with 15% lower energy consumption in 2024.

Report Coverage of Oxygen Concentrators Market

This Oxygen Concentrators Market Report covers global and regional market size, unit demand, and device segmentation. The report evaluates market share by type, with portable concentrators at 58% and stationary at 42%. Applications are analyzed with hospitals representing 49% demand, home healthcare 40%, and ambulatory centers 11%. Regional performance includes Asia-Pacific at 39% share, North America 27%, Europe 23%, and Middle East & Africa 11%. The competitive landscape highlights top companies, with Inogen and Philips holding 37% combined share. Trade, import-export data, and unit production volumes are included. The report provides insights into product development trends, patient demographics, and respiratory illness prevalence. Coverage spans investment opportunities, technological innovations, regulatory outlook, and new product launches, offering stakeholders a comprehensive Oxygen Concentrators Industry Report for 2025–2034.

Oxygen Concentrators Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 228.83 Million in 2026
Market Size Value By	USD 279.07 Million by 2035
Growth Rate	CAGR of 2.31% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Portable Stationary By Application : Hospital Home Healthcare Ambulatory Surgical Centers & Physician Offices
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample